Anzeige
Mehr »
Login
Montag, 06.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
Dow Jones News
146 Leser
Artikel bewerten:
(0)

Press Release: Report from Cavotec SA Ordinary -2-

Press Release: Report from Cavotec SA Ordinary General Meeting 2018

Cavotec SA ("the Company") today held its Ordinary General Meeting 
("OGM") in Lugano, Switzerland, chaired by Stefan Widegren. 
 
 
   1. Annual report, financial statements and consolidated financial statements 
      for the year 2017, report of the Statutory Auditors 
 
 
   The OGM adopted the Board of Directors' proposal that the annual report, 
the financial statements and the consolidated financial statement for 
the year 2017 be approved. 
 
 
   1.  Appropriation of available earnings 
 
 
   The OGM adopted the Board of Directors' proposal for the following 
appropriation: 
 
   CHF 
 
   Carried forward from previous year 
(19,612,363) 
 
   Net gain/ (loss) for the financial year 2017 
(22,135,641) 
 
   Total earnings available                                                         (41,748,004) 
 
 
   Appropriation to general statutory reserves                                                  0 
 
 
   Appropriation to other reserves                                                                   0 
 
 
   Proposed balance to be carried forward 
(41,748,004) 
 
 
   1. Grant of Discharge from Liability to the Board of Directors and Persons 
      entrusted with the Management from Activities during Business Year 2017 
 
 
   The OGM granted discharge to all members of the Board of Directors as 
well as the other persons entrusted with the management. 
 
 
   1.  Capital reduction through partial nominal value repayment 
 
 
   The OGM adopted the Board of Directors' proposal: 
 
   a) to reduce the current share capital of 102'096'800.00 by CHF 
1,570,720.00 to CHF 100,526,080.00 by way of reducing the nominal value 
of the registered shares from CHF 1.30 by CHF 0.02 to CHF 1.28 and to 
use the nominal value reduction amount for repayment to the 
shareholders; 
 
   b) to confirm as a result of the report of the auditors, that the claims 
of the creditors are fully covered notwithstanding the capital 
reduction; 
 
   c) to amend article 4, article 4ter, article 4quater para. 1, article 
4quinquies, article 4sexies, article 4septies and article 4octies of the 
Articles of Association according to the following wording as per the 
date of the entry of the capital reduction in the commercial register 
(the proposed amendments are in italics): 
 
   Article 4 
 
   "The share capital of the Company is CHF 100,526,080.00 and is divided 
into 78,536,000 fully paid registered shares. Each share has a par value 
of CHF 1.28." 
 
   Article 4ter 
 
   "The share capital may be increased in an amount not to exceed CHF 
913,884.16 through the issuance of up to 713,972 fully paid registered 
shares with a par value of CHF 1.28 per share by the issuance of new 
shares to employees of the Company and group companies. The pre-emptive 
rights and advance subscriptions rights of the shareholders of the 
Company shall thereby be excluded. The shares or rights to subscribe for 
shares shall be issued to employees pursuant to the Long Term Incentive 
Plan approved by the Board of Directors. Shares or subscription rights 
may be issued to employees at 10% discount compared with the market 
price quoted on the stock exchange of that time." 
 
   Article 4quater para. 1 
 
   "The Board of Directors shall be authorized to increase the share 
capital in an amount not to exceed CHF 20,105,216.00 through the 
issuance of up to 15,707,200 fully paid registered shares with a par 
value of CHF 1.28 per share by not later than April 22, 2018." 
 
   Article 4quinquies 
 
   "The share capital may be increased in an amount not to exceed CHF 
913,884.16 through the issuance of up to 713,972 fully paid registered 
shares with a par value of CHF 1.28 per share by the issuance of new 
shares to employees of the Company and group companies. The pre-emptive 
rights and advance subscriptions rights of the shareholders of the 
Company shall thereby be excluded. The shares or rights to subscribe for 
shares shall be issued to employees pursuant to the Long Term Incentive 
Plan 2013 approved by the Board of Directors. Shares or subscription 
rights may be issued to employees at 10% discount compared with the 
market price quoted on the stock exchange of that time." 
 
   Article 4sexies 
 
   "The share capital may be increased in an amount not to exceed CHF 
913,884.16 through the issuance of up to 713,972 fully paid registered 
shares with a par value of CHF 1.28 per share by the issuance of new 
shares to employees of the Company and group companies. The pre-emptive 
rights and advance subscriptions rights of the shareholders of the 
Company shall thereby be excluded. The shares or rights to subscribe for 
shares shall be issued to employees pursuant to the Long Term Incentive 
Plan 2014 approved by the Board of Directors. Shares or subscription 
rights may be issued to employees at 10% discount compared with the 
market price quoted on the stock exchange of that time." 
 
   Article 4septies 
 
   "The share capital may be increased in an amount not to exceed CHF 
1,005,260.80 through the issuance of up to 785,360 fully paid registered 
shares with a par value of CHF 1.28 per share by the issuance of new 
shares to employees of the Company and group companies. The pre-emptive 
rights and advance subscriptions rights of the shareholders of the 
Company shall thereby be excluded. The shares or rights to subscribe for 
shares shall be issued to employees pursuant to the Long Term Incentive 
Plan 2015 approved by the Board of Directors. Shares or subscription 
rights may be issued to employees at 10% discount compared with the 
market price quoted on the stock exchange of that time." 
 
   Article 4octies 
 
   "The share capital may be increased in an amount not to exceed CHF 
1,005,260.80 through the issuance of up to 785,360 fully paid registered 
shares with a par value of CHF 1.28 per share by the issuance of new 
shares to employees of the Company and group companies. The pre-emptive 
rights and advance subscriptions rights of the shareholders of the 
Company shall thereby be excluded. The shares or rights to subscribe for 
shares shall be issued to employees pursuant to the Long Term Incentive 
Plan 2016 approved by the Board of Directors. Shares or subscription 
rights may be issued to employees at a 10% discount compared with the 
market price quoted on the stock exchange at that time." 
 
   Explanatory notes: 
 
   In the event of approval of the proposed capital reduction, the nominal 
value reduction amount shall be repaid to shareholders. The capital 
reduction will be implemented after publication of the general meeting 
resolution in the Swiss Official Gazette of Commerce in accordance with 
Art. 733 Swiss Code of Obligations and the expiration of the 2 months 
notice period provided therein. Subject to approval by the general 
shareholders' meeting and to entry of the reduction in the Commercial 
Register, CHF 0.02 per share will be repaid to the shareholders, holding 
shares on July 6, 2018 prospectively on July 13, 2018. The capital 
reduction amount is paid out without deduction of Swiss withholding tax. 
 
 
   1. Creation of authorized share capital 
 
 
   The OGM adopted the Board of Directors' proposal to create authorized 
share capital in an amount not to exceed CHF 20,105,216.00, enabling the 
issuance of up to 15,707,200 Cavotec SA shares by not later than April 
12, 2020, by amending article 4quater, para. 1 of the Articles of 
Association with the following wording: 
 
   "The Board of Directors shall be authorized to increase the share 
capital in an amount not to exceed CHF 20,105,216.00 through the 
issuance of up to 15,707,200 fully paid registered shares with a par 
value of CHF 1.28 per share by not later than April 12, 2020. Increases 
in partial amounts shall be permitted." 
 
   The decision referred to the agenda item 4 concerning the amendments to 
the art. 4quater para. 1 is therefore superseded by this motion. 
 
 
   1.  Approval of Remuneration 
 
 
   The OGM approved the maximum aggregate amount (covering fixed and 
variable remuneration) each of: 
 
 
   -- the remuneration for the Board of Directors for the next business year 
 
   -- the remuneration for the CEO for the next business year. 
 
   6.1     Approval of Remuneration for the Board of Directors 
 
   The OGM approved the aggregate amount of EUR 1,000,000 for the 
remuneration for the Board of Directors for the business year 2019. 
 
   6.2     Approval of Remuneration of the CEO 
 
   The OGM approved the aggregate amount of EUR 1,500,000 for the 
remuneration for the CEO for the business year 2019. 
 
   7.     Re-election of five Directors, election of one new Director, 
nomination of the Chairman of the Board of Directors 
 
   In accordance with the Nomination Committee's proposal, Fabio Cannavale, 
Erik Lautmann, Patrik Tigerschiöld, Helena Thrap-Olsen, Heléne 
Mellquist were re-elected as Directors for a further one-year term of 
office expiring at the OGM to be held in 2019. Patrik Tigerschiöld 
was elected as Chairman of the Board of Directors for one-year term of 
office at the OGM to be held in 2019. Roberto Italia was elected as 
Director for a one-year term of office expiring at the Ordinary General 
Meeting to be held in 2019. 
 
 
   1. Nominations for the Remuneration Committee 
 
 
   In accordance with the Nomination Committee's proposal Erik Lautmann, 
Helena Thrap-Olsen and Patrik Tigerschiöld were elected as members 
of the Remuneration Committee. With respect to the requirements in the 
Code that all members of the Remuneration Committee, apart from the 
chairman of the Remuneration Committee, are to be independent of the 
company and its executive management, the Nomination Committee has come 
to the conclusion that all candidates proposed by the Board of Directors 
are independent of the company and its executive management. 
 
 
   1. Re-election of Independent Auditor 
 
 
   In accordance with the Nomination Committee's proposal, 
PricewaterhouseCoopers SA, Lugano, Switzerland was re-elected as 
Cavotec's independent auditor for the business year 2018. 
 
 

(MORE TO FOLLOW) Dow Jones Newswires

April 12, 2018 12:46 ET (16:46 GMT)

1.  Election of an Independent Proxy 
 
 
   In accordance with the Board of Directors' proposal, Mr. Franco Brusa, 
Attorney-at-law, Via G.B. Pioda 5, Lugano, Switzerland was elected as 
Cavotec's independent proxy for the OGM 2019. 
 
   ENDS 
 
   For further details please contact: 
 
   Johan Hähnel 
 
   Investor Relations Manager 
 
   Telephone: +46 70 605 63 34 - Email: investor@cavotec.com 
https://www.globenewswire.com/Tracker?data=jO4ZsIxRiKtcy__h3z3YoxewtAyw_6GceZqVYFiLRQ8763ZbMhuR892uzHTh3i55DVI64dAtZDJANZMfmpD30Z6jFopgnpxlErRBMeL8Luc= 
 
 
   About Cavotec 
 
   Cavotec is a leading engineering group that designs and manufactures 
automated connection and electrification systems for ports, airports and 
industrial applications worldwide. Cavotec innovative technologies 
ensure safe, efficient and sustainable operations. To find out more 
about Cavotec, visit our website at 
https://www.globenewswire.com/Tracker?data=NRS99yyqXakTAFqxvntCKJmsPwKd4TcAVn4AKjgs1TfUy8-hJBY1Pd_KSfeXXP5B8w0znzGSjFvAMariPRdjDA== 
cavotec.com. 
 
   The information in this release is subject to the disclosure 
requirements of Cavotec SA under the Swedish Securities Market Act 
and/or the Swedish Financial Instruments Trading Act. This information 
was publicly communicated on 12 April 2018, 18:45 CEST. 
 
 
 
 

(END) Dow Jones Newswires

April 12, 2018 12:46 ET (16:46 GMT)

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2018 Dow Jones News
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.